Compare Ginkgo Bioworks Holdings Inc (DNA) vs Infosys Limited (INFY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Infosys Limited — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.44 (market cap $505.73M), while Infosys Limited trades at $12.37 (market cap $50.55B). The key difference: Infosys Limited is far larger — about 100× Ginkgo Bioworks Holdings Inc's market cap, and Infosys Limited pays a 4.16% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | INFY | |
|---|---|---|
Market Cap | $505.73M | $50.55B |
Sector | Health | Technology |
52-Week High | $16.14 | $20.22 |
52-Week Low | $5.48 | $10.49 |
Enterprise Value | $607.68M | $48.30B |
Dividend Yield | — | 4.16% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Infosys Limited
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →
